Integration of Baseline Metabolic Parameters and Mutational Profiles Predicts Long-Term Response to First-Line Therapy in DLBCL Patients: A Post Hoc Analysis of the SAKK38/07 Study †.

Simple Summary: In this manuscript, we present a statistical model for reliable and early prediction of treatment failure in patients with diffuse large B-cell lymphoma. The model combines measurable parameters—namely, the metabolic tumor volume and the metabolic heterogeneity, from baseline PET/CT...

Descripción completa

Detalles Bibliográficos

Publicado en:	Cancers Vol. 14; no. 4; pp. 1018 - 1019
Autores principales:	Genta, Sofia, Ghilardi, Guido, Cascione, Luciano, Juskevicius, Darius, Tzankov, Alexandar, Schär, Sämi, Milan, Lisa, Pirosa, Maria Cristina, Esposito, Fabiana, Ruberto, Teresa, Giovanella, Luca, Hayoz, Stefanie, Mamot, Christoph, Dirnhofer, Stefan, Zucca, Emanuele, Ceriani, Luca
Formato:	research tables/charts Journal Article
Publicado:	MDPI Feb2022
Acceso en línea:	Ver este registro en EBSCOhost